Dawn Meyer 

Dawn M. Meyer 

Assistant Clinical Professor


Contact Information

UCSD Stroke Center
East Campus Office Building
9444 Medical Center Drive
La Jolla, CA 92093-0979

Email: dmmeyer@ucsd.edu
Phone: 619-543-2871

Dr. Meyer joined the UC San Diego Department of Neurosciences in April 2010 as an assistant professor. She completed her Bachelor of Science in Nursing at Nicholls State University and began work as a staff/charge nurse at MD Anderson Cancer Center of Houston, Texas. She completed her Master of Science in Nursing with a Family Nurse Practitioner concentration at the University of Texas Health Science Center at Houston.

After her certification as a family nurse practitioner, she was recruited to the University of Texas Stroke Team with James Grotta, MD. During this time, she gained expertise in stroke care and become involved as a co-investigator in numerous clinical trails. In 2005, she was recruited to Sharp Healthcare of San Diego to become the Director of Stroke Certification. In 2010, she completed her PhD in Nursing at the University of California Los Angles.

Dr. Meyer is a nationally certified family nurse practitioner. Her research focuses on the use of antiplatelet loading in acute stroke with a particular emphasis on sex differences in response to stroke and antiplatelet treatment. The rLOAD study has provided a scientifically rigorous preclinical evaluation of a cost-effective and easily accessible intervention and has explored the role of estrogen in stroke outcome for the first time in a non-rodent model of stroke.

The outcomes of this study will serve the 795,000 people – and the 55,000 more women than men – who suffer acute stroke each year by filling a gap in knowledge related to the understanding of the specific antiplatelet dosing that is safe and may lead to decreased in stroke burden. In addition, the role of estrogen has been explored for its mediating effects of estrogen in stroke treatment modulation.

Dr. Meyer’s clinical work focuses on the acute treatment of stroke patients and secondary stroke prevention. She is co-investigator in several stroke clinical trials with the UC San Diego Stroke Team.
2009 Meyer, DM. Antiplatelets and stroke outcomes: State of the science. Crit care Nurs Clin North Am, 2009; 21(4): 517-528.
2008 Meyer, DM, Albright, KC, Allison, TA, Grotta, JC. LOAD: A Pilot Study of the Safety of Loading of Aspirin and Clopidogrel in Acute Ischemic Stroke and TIA. Journal of Stroke and Cerebrovascular Diseases, 2008; 17(1): 26-29.
2008 Albright KC, Raman R, Ernstrom, K, Hallevi H, Martin-Schild S, Meyer BC, Meyer DM, Morales MM, Grotta JC, Lyden PD, Savitz SI. (2008). Can Comprehensive Stroke Centers Erase the ’Weekend Effect’?. Cerebrovascular diseases, 27(2), 107-113.
2006 Sugg RM, Pary JK, Uchino K, Baraniuk S, Shaltoni HM, Gonzales NR, Mikulik R, Garami Z, Shaw SG, Matherne DE, Moye LA, Alexandrov AV, Grotta JC. Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol. 2006 Aug: 63(8):1057-62.
2006 Sugg RM, Gonzales NR, Matherne DE, et al. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006;67:1053–1055.
2005 Sugg, R, Pary, J., Uchino, K., Ford, S., Matherne, D., Shaltoni, H., Gonzales, N., Shaw, S., Alexandrov, A., Grotta, J. t-PA Argatroban Stroke Study (TARTS). Stroke. 2005; 36:447.

Albright, KC; Branas, CC; Meyer, BC; Meyer, DM; Zivin, JA; Lyden, PD; Carr, BG. National Access to Primary Stroke Centers (PSC) and Impact of Using Air Ambulances to Improve Patient Access to PSCs. Archives of Neurology, in press.